Review Article

Interferons and Interferon Regulatory Factors in Malaria

Table 1

Combinations of different mouse backgrounds and parasite strains combinations allow the study of many disease profiles.

Mouse strainInfectionInfection/pathology/protectionRef.

C57BL/6
C57BL/6J
C57BL/6N
C57BL/6AnNCr
129/Ola x C57BL/6
129P2Sv/Ev
129 Sv/Ev x C57BL/6
P. berghei ANKAECM [61ā€“76]
P. berghei ANKA-luc (231c11) [21, 77]
P. berghei ANKA-GFP [78, 79]
P. berghei ANKA clone 15cy1[80, 81]
P. berghei ANKA-GFP clone 15cy1[82]
P. berghei ANKA clone BdS[26, 83]
P. berghei ANKA sporozoite[73]
P. berghei ANKA clone 15cy1 sporozoite[80, 84]

C57BL/6P. berghei K173Protection from ECM[67]
P. yoelii nigeriensis N67CLethal hyperparasitemia and severe anemia[85]
P. yoelii 17XNL Protection from lethal hyperparasitemia and severe anemia[86]
P. yoelii yoelii 265 BY uncloned line[87]
P. yoelii nigeriensis N67[85]
P. berghei NK65Liver injury[88]
Malaria-associated acute respiratory distress syndrome[76]
P. berghei NK65-GFPPlacental malaria[89]
P. chabaudi chabaudi AS Protection in uncomplicated malaria[77, 90]
P. chabaudi AS[76, 91]
P. berghei ANKA-luc sporozoiteLiver-stage malaria [92]
P. berghei NK65 sporozoite
P. yoelii 17XNL sporozoite

C57BL/6.C-H2 /bByP. berghei ANKA-GFP sporozoiteLiver-stage malaria[93]

CBA/JP. berghei ANKAECM[75]
P. yoelii 17XProtection from lethal hyperparasitemia and severe anemia [94]
P. yoelii 17XNL

CBA/T6P. berghei ANKAECM [95]
P. berghei K173Protection from ECM

CBA/CaHP. chabaudi adami 556 KAProtection against blood-stage malaria[96]

DBA/2P. berghei ANKAProtection from ECM [84]
Acute lung injury

129 Sv/EvP. berghei ANKA clone 1.4ECM[97]
P. chabaudi chabaudi ASProtection against blood-stage malaria[98]

BALB/cP. berghei ANKAProtection from ECM[65, 70, 74, 75, 84]
P. berghei ANKA clone BdS[26]
P. berghei ANKA-GFP[79]

BALB/cByJ
SW
P. yoelii 17XLLethal hyperparasitemia and severe anemia [94]
P. yoelii 17XNLProtection from lethal hyperparasitemia and severe anemia